Supply Notification: Reboxetine (Edronax) 4mg tablets

Supply Notification: Reboxetine (Edronax) 4mg tablets

November 28, 2019

Department of Health and Social Care (DHSC) has issued a supply disruption notification for Reboxetine (Edronax®) 4mg tablets. This is due to manufacturing issues.

Stock is expected to resume w/c 16 December 2019.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.



Posted in: ,


More Latest News >